An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines-Reference-Cited by-同舟云学术

An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines

Published:2022-02 Issue:9 Volume:40 Page:1208-1212
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Liu Fei,Feng Canbin,Xu Shiqi,Wu Qiang,Tang Jian,Chen Yan,Xu Ruisheng,Chen Fuliang,Gao Ni,Xu Zhengzheng,Gu Shihui,Lan Yang,Zhou Haibo,Hu Xinde,Wang Xiaojing

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Organization, W.H., Draft Landscape of COVID-19 Candidate Vaccines (20201112). 2020.

2. SARS-CoV-2 vaccines in development;Krammer;Nature,2020

3. Gene therapy for neurological disorders: progress and prospects;Deverman;Nat Rev Drug Discov,2018

4. Adeno-associated virus-vectored influenza vaccine elicits neutralizing and Fcgamma receptor-activating antibodies;Demminger;EMBO Mol Med,2020

5. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys;Johnson;Nat Med,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies;Advanced Science;2023-10-31

2. Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines;Expert Review of Vaccines;2023-05-10

3. Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants;Virology Journal;2022-12-09